Data, Walker, 1862
publication ID |
https://doi.org/10.1038/s41467-019-08438-0 |
DOI |
https://doi.org/10.5281/zenodo.5945287 |
persistent identifier |
https://treatment.plazi.org/id/03F98792-8955-FFEB-FC51-C6D8FD28FB0B |
treatment provided by |
Plazi (2019-02-07 12:44:07, last updated 2023-10-30 20:44:47) |
scientific name |
Data |
status |
|
Data View in CoL availability
Genomic data can be found at DOI: 10.5281/zenodo.2436565. All other data are available in the main text or the supplementary materials; Permits for collections and accessing genetic resources in Brazil were issued by SISBIO #46555 – 5 and CNPq # 010936 /2014 – 9. Costa Rican collecting permits were issued by the Comisión Institucional de Biodiversidad (Institutional Biodiversity Committee, University of Costa Rica; Resolutions # 0 12 and 020; Material Transfer Agreement MTA VI-4307 – 2013) and authorized by La Selva Biological Station and Las Brisas Nature Reserve. A modified version of the southern pine beetle ( Fig. 1 View Fig. 1 ) photo from Erich G. Vallery is used under the Creative Commons Attribution 3.0 License. Photos of Cyphomyrmex ( Figs. 1 View Fig. 1 and 5 View Fig. 5 ) are used under a perpetual commercial license from Alexander Wild.
Received: 18 October 2018 Accepted: 11 January 2019
Fig. 1 Sampling strategy for Streptomyces from insect microbiomes. Streptomyces were isolated from a wide range of insects and geographies (1445 insects; 10,178 strains; dot size, insects sampled). Streptomyces production of the antifungal mycangimycin (1) in the Southern Pine Beetle system is shown at right. Cyphomycin (2) is a new antifungal described herein. Photo credits: southern pine beetle - Erich G. Vallery; fungus-growing ant – Alexander Wild
Fig. 5 Insect-associated Streptomyces are a source of active antimicrobials. a Fractionated extracts from insect microbiomes are active in multiple murine models of drug-resistant infection. Less infective burden is seen in intraperitoneally treated mice after 8 h of infection. Each dot represents a unique fraction in one mouse study. (n = 15, 11, and 8 for C. albicans, E. coli, and P. aeruginosa models, respectively; center, median; box, upper and lower quantiles; whiskers, 1.5× interquartile range. b Most fractions from insect microbiomes show no hemolysis in cell-based assays. Safe indicates no toxicity at>100× concentration associated with efficacy. c The antifungal cyphomycin is produced by Streptomyces isolated from d the fungus-growing ant Cyphomyrmex sp. Photo credit: Alexander Wild e Cyphomycin-containing fractions show potency against the ant pathogen Escovopsis sp. (top left, bottom). f Purified cyphomycin exhibits potency against resistant pathogens. g Mouse candidiasis (C. albicans) models showcase reduced infection and a dose-like response to cyphomycin. Dots indicate individual mice
No known copyright restrictions apply. See Agosti, D., Egloff, W., 2009. Taxonomic information exchange and copyright: the Plazi approach. BMC Research Notes 2009, 2:53 for further explanation.